October 18, 2019 by Amanpreet
With the rise in emphasis on prevention and treatment of proliferative vitreoretinopathy (PVR), a serious ailment that leads to blindness despite repeated treatment, the requirement for vitreoretinal centers has gained importance worldwide. Prevention of PVR development at early stage RRD for preserving visual function in patients has become a primary agenda among medical researchers and clinicians. A recent Fact.MR analysis envisages the proliferative vitreoretinopathy market to reflect a modest 4.0% CAGR during the forecast period (2018-2027).
Read Report Summary: https://www.factmr.com/report/795/proliferative-vitreoretinopathy-market
To get Intensive Insights: https://www.factmr.com/connectus/sample?flag=RM&rep_id=795
Check out the Sample Report here: https://www.factmr.com/connectus/sample?flag=S&rep_id=795